Skip to content

The outcomes of combined endoscopic surgery and fibrinolytic treatment protocol for intraventricular hemorrhage

The outcomes of combined endoscopic surgery and fibrinolytic treatment protocol for intraventricular hemorrhage: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191122002
Enrollment
210
Registered
2019-11-22
Start date
2018-08-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous intraventricular hemorrhage secondary intraventricular hemorrhage from spontaneous intracerebral hemorhage obstructive hydrocephalus intraventricular hemorrhage hydrocephalus fibrinolytic agent endoscopic removal

Interventions

external ventricular drainage plus fibrinolytic agents and/or endoscopic intraventricular clot removal,external ventricular drainage alone
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. age 18-80 years 2. onset less than 24 hours prior to CT brain 3. primary intraventricular hemorrhage or secondary from spontaneous intracerebral hemorrhage less than 20 ml 4. obstructive hydrocephalus from blood clot in 3rd or 4th ventricles 5. SBP < 200 mmHg or MAP <130 mmHg prior to treatment 6. Modified Rankin Scale 0 or 1 before onset

Exclusion criteria

Exclusion criteria: 1. Ruptured aneurysm, arteriovenous malformation (AVM), vascular anomaly, Moya-moya disease disease or tumor 2. previous brain surgery less than 3 months 3. uncorrectable bleeding disorders, platelet count less than 100,000, or INR more than 1.3 4. pregnancy 5. infratentorium hemorrhage 6. severe unstable medical conditions such as uncontrolled cardiac disease 7. subjects refuse to participate, unidentifiable subject, or unable to find consent for subject

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (mRS) Posttreatment 6 month mRS 0-3 vs 0-6

Secondary

MeasureTime frame
Modified Rankin Scale (mRS) Posttreatment 3 month mRS 0-3 vs 0-6,Mortality rate entire study mortality event,Quality of life Posttreatment 1, 3 and 6month EQ 5D 5L,Rate of shunt surgery entire study event of shunt surgery,Complications entire study complication event rate

Countries

Thailand

Contacts

Public ContactRaywat Noiphithak

Thammasat University Hospital

raywat_n@tu.ac.th6629269523

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026